Advertisement

Congenital Aortopathy

  • Matina PrapaEmail author
  • M. A. Gatzoulis
Chapter

Abstract

Aortic dilatation has become more prevalent in congenital heart disease as a result of reparative surgery prolonging survival. Over the past decades, there has been an increased focus on aortic aneurysm formation associated with connective tissue disorders, such as Marfan syndrome and bicuspid aortic valve (BAV) disease, unravelling many of the underlying pathophysiologic mechanisms. In contrast, our depth of knowledge on congenital aortopathy is lagging behind. This chapter provides an overview of less common congenital heart disease lesions associated with aortic dilatation and discusses current updates on their evaluation and management.

Keywords

Congenital heart disease Aneurysm Aorta Aortic dissection 

References

  1. 1.
    Dietz HC, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–9.CrossRefGoogle Scholar
  2. 2.
    El-Hamamsy I, Yacoub MH. Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol. 2009;6:771–86.CrossRefGoogle Scholar
  3. 3.
    Zanjani KS, Niwa K. Aortic dilatation and aortopathy in congenital heart diseases. J Cardiol. 2013;61:16–21.CrossRefGoogle Scholar
  4. 4.
    Bahnson HT, et al. Surgical treatment and follow-up of 147 cases of tetralogy of Fallot treated by correction. J Thorac Cardiovasc Surg. 1962;44:419–32.PubMedGoogle Scholar
  5. 5.
    Bull K, Somerville J, Ty E, Spiegelhalter D. Presentation and attrition in complex pulmonary atresia. J Am Coll Cardiol. 1995;25:491–9.CrossRefGoogle Scholar
  6. 6.
    Marelli AJ, Perloff JK, Child JS, Laks H. Pulmonary atresia with ventricular septal defect in adults. Circulation. 1994;89:243–51.CrossRefGoogle Scholar
  7. 7.
    Niwa K, Siu SC, Webb GD, Gatzoulis MA. Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot. Circulation. 2002;106:1374–8.CrossRefGoogle Scholar
  8. 8.
    Jonsson H, Ivert T, Brodin LA. Echocardiographic findings in 83 patients 13-26 years after intracardiac repair of tetralogy of Fallot. Eur Heart J. 1995;16:1255–63.CrossRefGoogle Scholar
  9. 9.
    Bhat AH, Smith CJ, Hawker RE. Late aortic root dilatation in tetralogy of Fallot may be prevented by early repair in infancy. Pediatr Cardiol. 2004;25:654–9.CrossRefGoogle Scholar
  10. 10.
    Tan JL, Davlouros PA, McCarthy KP, Gatzoulis MA, Ho SY. Intrinsic histological abnormalities of aortic root and ascending aorta in tetralogy of Fallot: evidence of causative mechanism for aortic dilatation and aortopathy. Circulation. 2005;112:961–8.CrossRefGoogle Scholar
  11. 11.
    Kim WH, et al. Aortic dissection late after repair of tetralogy of Fallot. Int J Cardiol. 2005;101:515–6.CrossRefGoogle Scholar
  12. 12.
    Dodds GA, Warnes CA, Danielson GK. Aortic valve replacement after repair of pulmonary atresia and ventricular septal defect or tetralogy of Fallot. J Thorac Cardiovasc Surg. 1997;113:736–41.CrossRefGoogle Scholar
  13. 13.
    Cheung YF, Hong WJ, Chan KW, Wong SJ. Modulating effects of matrix metalloproteinase-3 and -9 polymorphisms on aortic stiffness and aortic root dilation in patients after tetralogy of Fallot repair. Int J Cardiol. 2011;151:214–7.CrossRefGoogle Scholar
  14. 14.
    Chowdhury UK, et al. Role of fibrillin-1 genetic mutations and polymorphism in aortic dilatation in patients undergoing intracardiac repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2008;136:757–66.CrossRefGoogle Scholar
  15. 15.
    John AS, Rychik J, Khan M, Yang W, Goldmuntz E. 22q11.2 deletion syndrome as a risk factor for aortic root dilation in tetralogy of Fallot. Cardiol Young. 2014;24:303–10.CrossRefGoogle Scholar
  16. 16.
    Senzaki H, et al. Arterial haemodynamics in patients after repair of tetralogy of Fallot: influence on left ventricular after load and aortic dilatation. Heart. 2008;94:70–4.CrossRefGoogle Scholar
  17. 17.
    Rathi VK, et al. Massive aortic aneurysm and dissection in repaired tetralogy of Fallot; diagnosis by cardiovascular magnetic resonance imaging. Int J Cardiol. 2005;101:169–70.CrossRefGoogle Scholar
  18. 18.
    Wijesekera VA, et al. Aortic dissection in a patient with a dilated aortic root following tetralogy of Fallot repair. Int J Cardiol. 2014;174:833–4.CrossRefGoogle Scholar
  19. 19.
    Konstantinov IE, Fricke TA, d’Udekem Y, Robertson T. Aortic dissection and rupture in adolescents after tetralogy of Fallot repair. J Thorac Cardiovasc Surg. 2010;140:71–3.CrossRefGoogle Scholar
  20. 20.
    Guo T, et al. Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients. Hum Mutat. 2011;32:1278–89.CrossRefGoogle Scholar
  21. 21.
    Niwa K, et al. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation. 2001;103:393–400.CrossRefGoogle Scholar
  22. 22.
    John AS, McDonald-McGinn DM, Zackai EH, Goldmuntz E. Aortic root dilation in patients with 22q11.2 deletion syndrome. Am J Med Genet A. 2009;149A:939–42.CrossRefGoogle Scholar
  23. 23.
    Carlo WF, McKenzie ED, Slesnick TC. Root dilation in patients with truncus arteriosus. Congenit Heart Dis. 2011;6:228–33.CrossRefGoogle Scholar
  24. 24.
    Frischhertz BP, Shamszad P, Pedroza C, Milewicz DM, Morris SA. Thoracic aortic dissection and rupture in conotruncal cardiac defects: a population-based study. Int J Cardiol. 2015;184:521–7.CrossRefGoogle Scholar
  25. 25.
    Gutierrez PS, Binotto MA, Aiello VD, Mansur AJ. Chest pain in an adult with truncus arteriosus communis. Am J Cardiol. 2004;93:272–3.CrossRefGoogle Scholar
  26. 26.
    Gatzoulis MA. Ross procedure: the treatment of choice for aortic valve disease? Int J Cardiol. 1999;71:205–6.CrossRefGoogle Scholar
  27. 27.
    Charitos EI, et al. Reoperations on the pulmonary autograft and pulmonary homograft after the Ross procedure: an update on the German Dutch Ross registry. J Thorac Cardiovasc Surg. 2012;144:813–21.CrossRefGoogle Scholar
  28. 28.
    David TE, et al. Dilation of the pulmonary autograft after the Ross procedure. J Thorac Cardiovasc Surg. 2000;119:210–20.CrossRefGoogle Scholar
  29. 29.
    David TE. Ross procedure at the crossroads. Circulation. 2009;119:207–9.CrossRefGoogle Scholar
  30. 30.
    Horer J, et al. Neoaortic root diameters and aortic regurgitation in children after the Ross operation. Ann Thorac Surg. 2009;88:594–600.CrossRefGoogle Scholar
  31. 31.
    Hokken RB, et al. Does the pulmonary autograft in the aortic position in adults increase in diameter? An echocardiographic study. J Thorac Cardiovasc Surg. 1997;113:667–74.CrossRefGoogle Scholar
  32. 32.
    Solymar L, Sudow G, Holmgren D. Increase in size of the pulmonary autograft after the Ross operation in children: growth or dilation? J Thorac Cardiovasc Surg. 2000;119:4–9.CrossRefGoogle Scholar
  33. 33.
    Luciani GB, et al. Fate of the aortic root late after Ross operation. Circulation. 2003;108:S61–7.CrossRefGoogle Scholar
  34. 34.
    Simon-Kupilik N, et al. Dilatation of the autograft root after the Ross operation. Eur J Cardiothorac Surg. 2002;21:470–3.CrossRefGoogle Scholar
  35. 35.
    de Sa M, Moshkovitz Y, Butany J, David TE. Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the ross procedure. J Thorac Cardiovasc Surg. 1999;118:588–94.CrossRefGoogle Scholar
  36. 36.
    Takkenberg JJ, et al. The Ross procedure: a systematic review and meta-analysis. Circulation. 2009;119:222–8.CrossRefGoogle Scholar
  37. 37.
    Settepani F, et al. The Ross operation: an evaluation of a single institution’s experience. Ann Thorac Surg. 2005;79:499–504.CrossRefGoogle Scholar
  38. 38.
    Schoof PH, et al. Degeneration of the pulmonary autograft: an explant study. J Thorac Cardiovasc Surg. 2006;132:1426–32.CrossRefGoogle Scholar
  39. 39.
    Matsuki O, et al. Two decades’ experience with aortic valve replacement with pulmonary autograft. J Thorac Cardiovasc Surg. 1988;95:705–11.PubMedGoogle Scholar
  40. 40.
    Alsoufi B, et al. Cardiac reoperations following the Ross procedure in children: spectrum of surgery and reoperation results. Eur J Cardiothorac Surg. 2012;42:25–30.CrossRefGoogle Scholar
  41. 41.
    Kincaid EH, Maloney JD, Lavender SW, Kon ND. Dissection in a pulmonary autograft. Ann Thorac Surg. 2004;77:707–8.CrossRefGoogle Scholar
  42. 42.
    Rabkin DG, Reid BB, Doty JR. Acute on chronic pulmonary autograft dissection. Interact Cardiovasc Thorac Surg. 2015;20:563–4.CrossRefGoogle Scholar
  43. 43.
    Venkataraman R, Vaidyanathan KR, Sankar MN, Cherian KM. Late dissection of pulmonary autograft treated by valve-sparing aortic root replacement. J Card Surg. 2009;24:443–5.CrossRefGoogle Scholar
  44. 44.
    Rabkin-Aikawa E, et al. Clinical pulmonary autograft valves: pathologic evidence of adaptive remodeling in the aortic site. J Thorac Cardiovasc Surg. 2004;128:552–61.CrossRefGoogle Scholar
  45. 45.
    Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis. 2004;13:841–7.PubMedGoogle Scholar
  46. 46.
    Prapa M, Dimopoulos K. Arterial switch repair to transposition of great arteries: so far so good. Int J Cardiol. 2012;160:1–3.CrossRefGoogle Scholar
  47. 47.
    Losay J, et al. Late outcome after arterial switch operation for transposition of the great arteries. Circulation. 2001;104:121–6.CrossRefGoogle Scholar
  48. 48.
    Vandekerckhove KD, et al. Long-term follow-up of arterial switch operation with an emphasis on function and dimensions of left ventricle and aorta. Eur J Cardiothorac Surg. 2009;35:582–7.CrossRefGoogle Scholar
  49. 49.
    Schwartz ML, Gauvreau K, del Nido P, Mayer JE, Colan SD. Long-term predictors of aortic root dilation and aortic regurgitation after arterial switch operation. Circulation. 2004;110:128–32.CrossRefGoogle Scholar
  50. 50.
    Hutter PA, et al. Fate of the aortic root after arterial switch operation. Eur J Cardiothorac Surg. 2001;20:82–8.CrossRefGoogle Scholar
  51. 51.
    Bove T, et al. Midterm assessment of the reconstructed arteries after the arterial switch operation. Ann Thorac Surg. 2008;85:823–30.CrossRefGoogle Scholar
  52. 52.
    Takeuchi T. Histological analysis of ascending aorta and proximal pulmonary artery in patients with one-stage Jatene procedure. Acta Pediatr Cardiol Jpn. 1996;12:506–12.Google Scholar
  53. 53.
    Agnoletti G, et al. Acute angulation of the aortic arch predisposes a patient to ascending aortic dilatation and aortic regurgitation late after the arterial switch operation for transposition of the great arteries. J Thorac Cardiovasc Surg. 2008;135:568–72.CrossRefGoogle Scholar
  54. 54.
    Ono M, et al. Valve-sparing operation for aortic root aneurysm late after mustard procedure. Ann Thorac Surg. 2007;83:2224–6.CrossRefGoogle Scholar
  55. 55.
    Nowitz A. Acute ascending aortic dissection 41 years after mustard procedure. J Cardiothorac Vasc Anesth. 2013;27:735–9.CrossRefGoogle Scholar
  56. 56.
    Cohen MS, et al. Neo-aortic root dilation and valve regurgitation up to 21 years after staged reconstruction for hypoplastic left heart syndrome. J Am Coll Cardiol. 2003;42:533–40.CrossRefGoogle Scholar
  57. 57.
    Fitzgerald KK, Bhat AM, Conard K, Hyland J, Pizarro C. Novel SMAD3 mutation in a patient with hypoplastic left heart syndrome with significant aortic aneurysm. Case Rep Genet. 2014;2014:591516.PubMedPubMedCentralGoogle Scholar
  58. 58.
    van de Laar IM, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet. 2011;43:121–6.CrossRefGoogle Scholar
  59. 59.
    Erez E, et al. Valve-sparing aortic root replacement for patients with a Fontan circulation. J Heart Valve Dis. 2012;21:175–80.PubMedGoogle Scholar
  60. 60.
    Pizarro C, Baffa JM, Derby CD, Krieger PA. Valve-sparing neo-aortic root replacement after Fontan completion for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2011;141:1083–4.CrossRefGoogle Scholar
  61. 61.
    Shuhaiber JH, et al. Repair of symptomatic neoaortic aneurysm after third-stage palliation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2006;131:478–9.CrossRefGoogle Scholar
  62. 62.
    Egan M, Phillips A, Cook SC. Aortic dissection in the adult Fontan with aortic root enlargement. Pediatr Cardiol. 2009;30:562–3.CrossRefGoogle Scholar
  63. 63.
    Dearani JA, Burkhart HM, Stulak JM, Sundt TM, Schaff HV. Management of the aortic root in adult patients with conotruncal anomalies. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009;12:122–9.CrossRefGoogle Scholar
  64. 64.
    Chong WY, Wong WH, Chiu CS, Cheung YF. Aortic root dilation and aortic elastic properties in children after repair of tetralogy of Fallot. Am J Cardiol. 2006;97:905–9.CrossRefGoogle Scholar
  65. 65.
    Hiratzka LF, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121:266–369.Google Scholar
  66. 66.
    Yetman AT, Graham T. The dilated aorta in patients with congenital cardiac defects. J Am Coll Cardiol. 2009;53:461–7.CrossRefGoogle Scholar
  67. 67.
    Francois K. Aortopathy associated with congenital heart disease: a current literature review. Ann Pediatr Cardiol. 2015;8:25–36.CrossRefGoogle Scholar
  68. 68.
    Geiger J, et al. 4D-MR flow analysis in patients after repair for tetralogy of Fallot. Eur Radiol. 2011;21:1651–7.CrossRefGoogle Scholar
  69. 69.
    Baumgartner H, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915–57.CrossRefGoogle Scholar
  70. 70.
    Silversides CK, et al. Canadian cardiovascular society 2009 consensus conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan’s syndrome. Can J Cardiol. 2010;26:80–97.CrossRefGoogle Scholar
  71. 71.
    Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation. 2005;111:150–7.CrossRefGoogle Scholar
  72. 72.
    Brooke BS, et al. Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. N Engl J Med. 2008;358:2787–95.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Clinical GeneticsAddenbrooke’s HospitalCambridgeUK
  2. 2.Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton HospitalThe National Heart and Lung Institute, Imperial CollegeLondonUK

Personalised recommendations